| 131I Ablation therapy based on a dosimetric method of metastatic thyroid papillary carcinoma in a hemodialysis patient |
|
, , , , , , |
|
울산대학교 의과대학 내과학교실 |
| 증례 : 혈액투석 환자에서 방사선량 측정 방법을 이용한 갑상샘 유두암의 방사성 요오드 치료 |
|
성주영&#;최은영&#;윤민기&#;황경훈&#;최원식&#;이기영&#;이준승, , , , , , |
|
|
|
|
|
|
| Abstract |
|
As removing iodide from the body occurs by renal excretion, radioiodine treatment in patients on hemodialysis requires an adjustment of dosages, timing of administration and usage of standardized safety guidelines. We present a case of papillary thyroid carcinoma in a hemodialysis patient who was successfully treated with postoperative 131I therapy while continuing the hemodialysis schedule. The appropriate 131I dosage, which was smaller than that for patients with normal renal function, was calculated from the results of the diagnostic scan and dosimetry. After 4 hours of hemodialysis that was performed 43 hours after iodine therapy, the patient's whole blood radioactivity decreased by 78% and whole body radiation exposure was decreased by 74%. There was no significant radiation exposure to the staff and the dialysis machine. No adverse effect was found to have been suffered by the patient.(Korean J Med 71:S1066-S1072, 2006) |
| Key Words:
Hemodialysis, Iodine radioisotopes, Thyroid Cancer |
|
PDF Links
Full text via DOI
Download Citation
